Bouchey Financial Group LTD Bristol Myers Squibb CO Transaction History

Bouchey Financial Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $10,316 - $11,701	157 Added 5.36%	3,086 $213,000
Q3 2022 Oct 26, 2022	BUY	$0.13 - $76.84 $380 - $225,064	2,929 New	2,929 $208,000
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $212,703 - $234,261	-2,929 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $180,074 - $215,925	2,929 New	2,929 $214,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bouchey Financial Group LTD, based on Form 13F filings with the SEC.

Stay updated on Bouchey Financial Group LTD with notifications on news.